Resistance of Cancer Cells to CTL-Mediated Immunotherapy
Produktnummer:
18f80619f160cd40ecac89c6048e9c611d
| Themengebiete: | HDAC inhibitors Proteasome inhibitors antibacterial drug resistance apoptosis cytotoxic t lymphocytes drug-resistant cancer cells epitopes |
|---|---|
| Veröffentlichungsdatum: | 30.06.2015 |
| EAN: | 9783319178066 |
| Sprache: | Englisch |
| Seitenzahl: | 353 |
| Produktart: | Gebunden |
| Herausgeber: | Bonavida, Benjamin Chouaib, Salem |
| Verlag: | Springer International Publishing |
Produktinformationen "Resistance of Cancer Cells to CTL-Mediated Immunotherapy"
This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.
Sie möchten lieber vor Ort einkaufen?
Sie haben Fragen zu diesem oder anderen Produkten oder möchten einfach gerne analog im Laden stöbern? Wir sind gerne für Sie da und beraten Sie auch telefonisch.
Juristische Fachbuchhandlung
Georg Blendl
Parcellistraße 5 (Maxburg)
8033 München
Montag - Freitag: 8:15 -18 Uhr
Samstags geschlossen